131 related articles for article (PubMed ID: 8083225)
1. Oxazaphosphorine-specific resistance in human MCF-7 breast carcinoma cell lines expressing transfected rat class 3 aldehyde dehydrogenase.
Bunting KD; Lindahl R; Townsend AJ
J Biol Chem; 1994 Sep; 269(37):23197-203. PubMed ID: 8083225
[TBL] [Abstract][Full Text] [Related]
2. Protection by transfected rat or human class 3 aldehyde dehydrogenase against the cytotoxic effects of oxazaphosphorine alkylating agents in hamster V79 cell lines. Demonstration of aldophosphamide metabolism by the human cytosolic class 3 isozyme.
Bunting KD; Townsend AJ
J Biol Chem; 1996 May; 271(20):11891-6. PubMed ID: 8662659
[TBL] [Abstract][Full Text] [Related]
3. De novo expression of transfected human class 1 aldehyde dehydrogenase (ALDH) causes resistance to oxazaphosphorine anti-cancer alkylating agents in hamster V79 cell lines. Elevated class 1 ALDH activity is closely correlated with reduction in DNA interstrand cross-linking and lethality.
Bunting KD; Townsend AJ
J Biol Chem; 1996 May; 271(20):11884-90. PubMed ID: 8662658
[TBL] [Abstract][Full Text] [Related]
4. Identification of a methylcholanthrene-induced aldehyde dehydrogenase in a human breast adenocarcinoma cell line exhibiting oxazaphosphorine-specific acquired resistance.
Sreerama L; Sladek NE
Cancer Res; 1994 Apr; 54(8):2176-85. PubMed ID: 8174125
[TBL] [Abstract][Full Text] [Related]
5. Human breast adenocarcinoma MCF-7/0 cells electroporated with cytosolic class 3 aldehyde dehydrogenases obtained from tumor cells and a normal tissue exhibit differential sensitivity to mafosfamide.
Sreerama L; Sladek NE
Drug Metab Dispos; 1995 Oct; 23(10):1080-4. PubMed ID: 8654195
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of a novel class 3 aldehyde dehydrogenase overexpressed in a human breast adenocarcinoma cell line exhibiting oxazaphosphorine-specific acquired resistance.
Sreerama L; Sladek NE
Biochem Pharmacol; 1993 Jun; 45(12):2487-505. PubMed ID: 8328987
[TBL] [Abstract][Full Text] [Related]
7. Intrinsic cellular resistance to oxazaphosphorines exhibited by a human colon carcinoma cell line expressing relatively large amounts of a class-3 aldehyde dehydrogenase.
Rekha GK; Sreerama L; Sladek NE
Biochem Pharmacol; 1994 Nov; 48(10):1943-52. PubMed ID: 7986206
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the human aldehyde dehydrogenase class I results in increased resistance to 4-hydroperoxycyclophosphamide.
Moreb J; Schweder M; Suresh A; Zucali JR
Cancer Gene Ther; 1996; 3(1):24-30. PubMed ID: 8785707
[TBL] [Abstract][Full Text] [Related]
9. Dependence of aldehyde dehydrogenase-mediated oxazaphosphorine resistance on soluble thiols: importance of thiol interactions with the secondary metabolite acrolein.
Bunting KD; Townsend AJ
Biochem Pharmacol; 1998 Jul; 56(1):31-9. PubMed ID: 9698086
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human class 3 aldehyde dehydrogenase, and sensitization of tumor cells that express significant amounts of this enzyme to oxazaphosphorines, by chlorpropamide analogues.
Rekha GK; Devaraj VR; Sreerama L; Lee MJ; Nagasawa HT; Sladek NE
Biochem Pharmacol; 1998 Feb; 55(4):465-74. PubMed ID: 9514081
[TBL] [Abstract][Full Text] [Related]
11. Phenolic antioxidant-induced overexpression of class-3 aldehyde dehydrogenase and oxazaphosphorine-specific resistance.
Sreerama L; Rekha GK; Sladek NE
Biochem Pharmacol; 1995 Mar; 49(5):669-75. PubMed ID: 7887982
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of aldophosphamide by human aldehyde dehydrogenase isozyme 3.
Giorgianni F; Bridson PK; Sorrentino BP; Pohl J; Blakley RL
Biochem Pharmacol; 2000 Aug; 60(3):325-38. PubMed ID: 10856427
[TBL] [Abstract][Full Text] [Related]
13. In vitro selection for K562 cells with higher retrovirally mediated copy number of aldehyde dehydrogenase class-1 and higher resistance to 4-hydroperoxycyclophosphamide.
Moreb JS; Schweder M; Gray B; Zucali J; Zori R
Hum Gene Ther; 1998 Mar; 9(5):611-9. PubMed ID: 9551609
[TBL] [Abstract][Full Text] [Related]
14. Multienzyme-mediated stable and transient multidrug resistance and collateral sensitivity induced by xenobiotics.
Rekha GK; Sladek NE
Cancer Chemother Pharmacol; 1997; 40(3):215-24. PubMed ID: 9219504
[TBL] [Abstract][Full Text] [Related]
15. Restoration of sensitivity to oxazaphosphorines by inhibitors of aldehyde dehydrogenase activity in cultured oxazaphosphorine-resistant L1210 and cross-linking agent-resistant P388 cell lines.
Sladek NE; Landkamer GJ
Cancer Res; 1985 Apr; 45(4):1549-55. PubMed ID: 3978623
[TBL] [Abstract][Full Text] [Related]
16. Development of selective inhibitors for human aldehyde dehydrogenase 3A1 (ALDH3A1) for the enhancement of cyclophosphamide cytotoxicity.
Parajuli B; Georgiadis TM; Fishel ML; Hurley TD
Chembiochem; 2014 Mar; 15(5):701-12. PubMed ID: 24677340
[TBL] [Abstract][Full Text] [Related]
17. Characterization of cytosolic aldehyde dehydrogenase from cyclophosphamide resistant L1210 cells.
Russo JE; Hilton J
Cancer Res; 1988 Jun; 48(11):2963-8. PubMed ID: 3365687
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of aldehyde dehydrogenases in murine tumor and hematopoietic progenitor cells to inhibition by chloral hydrate as determined by the ability of chloral hydrate to potentiate the cytotoxic action of mafosfamide.
Maki PA; Sladek NE
Biochem Pharmacol; 1993 Jan; 45(1):231-9. PubMed ID: 8424816
[TBL] [Abstract][Full Text] [Related]
19. The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance.
Moreb JS; Ucar D; Han S; Amory JK; Goldstein AS; Ostmark B; Chang LJ
Chem Biol Interact; 2012 Jan; 195(1):52-60. PubMed ID: 22079344
[TBL] [Abstract][Full Text] [Related]
20. Effect of aldehyde dehydrogenase inhibitors on the ex vivo sensitivity of human multipotent and committed hematopoietic progenitor cells and malignant blood cells to oxazaphosphorines.
Kohn FR; Landkamer GJ; Manthey CL; Ramsay NK; Sladek NE
Cancer Res; 1987 Jun; 47(12):3180-5. PubMed ID: 3034402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
